Nav: Home

How the tuberculosis vaccine may protect against other diseases

December 06, 2016

The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear. A study published December 6 in Cell Reports now shows that the broad-spectrum effects of the Bacillus Calmette-Guerin (BCG) vaccine--the most widely used vaccine in the world--could be mediated by metabolic and epigenetic changes in white blood cells called monocytes through a process called trained immunity. This discovery could pave the way for strategies that combine immunological and metabolic stimulation to boost the effectiveness of vaccines and anti-cancer therapies.

"The implications of these findings are double: On the one hand, we have uncovered new biological interactions that link cellular metabolism with immune responses, and on the other hand, we have opened the door for new therapeutic approaches in which metabolism modulators modulate innate immune responses and can serve as potential novel immunotherapies," says senior study author Mihai Netea of Radboud University Medical Center. "However, what it is important to realize is that this is the beginning of the process to bring this to clinical practice, and more studies are needed for that."

Many epidemiological studies have demonstrated BCG's capacity to protect against infections other than tuberculosis. For example, early administration of the BCG vaccine reduces child mortality, mainly due to a reduction in lower respiratory infections and harmful immune responses triggered by infections. BCG is also used to treat bladder cancer and appears to be beneficial in several other conditions, including asthma and parasitic diseases. However, it has not been clear exactly how BCG exerts its wide-ranging effects.

To address this question, Netea and his team examined BCG-induced metabolic changes in innate immune cells called monocytes. They found that vaccination induced a strong, long-lasting increase in glycolysis and, to a lesser extent, glutamine metabolism in mice and humans. This shift in glucose metabolism toward glycolysis was necessary to trigger trained immunity. This process relies on epigenetic changes, which affect gene activity without altering the DNA sequence, to enhance the ability of innate immune cells to recognize and mount more effective responses against previously encountered pathogens.

Specifically, BCG-induced metabolic changes were required to induce modifications to proteins called histones, which act as scaffolds around which DNA wraps. In the human cohorts, single-nucleotide variations in genes encoding glycolysis enzymes affected the induction of trained immunity in monocytes. Taken together, the results show that cellular metabolism reprogramming is a central process involved in BCG-induced trained immunity.

"These findings change the concept that the innate immune system cannot adapt in the long-term after an infection or vaccination," Netea says. "The whole concept that the function of innate immune cells can change in a stable way, for example, being improved by certain vaccines such as BCG, is a paradigm shift in immunology, as until not too long ago it was assumed that only the adaptive immune system can adapt to previous infections or vaccinations."

Host immune responses are classically divided into innate immune responses, which react rapidly and nonspecifically upon encountering a pathogen, and adaptive immune responses, which are slower to develop but are specific and build up immunological memory, Netea explains. The discovery of trained immunity has challenged the dogma that only adaptive immunity can build immunological memory.

According to Netea, the next step is to conduct a bigger, broader analysis of circulating monocytes in BCG-vaccinated individuals at risk for infections. "In the future, bigger studies should assess inter-individual variation in these responses, in order to be able to identify which factors influence vaccination responses at the level of a person," Netea says. "In the end, a better understanding of BCG-induced trained immunity could lead to the development of strategies that alter cellular metabolism pathways to improve human host defense mechanisms and boost the effectiveness of vaccines and immunotherapy in patients."
-end-
The researchers were supported by the European Research Council; the Netherlands Organization for Scientific Research; the Northern Portugal Regional Operational Programme, under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund; and the Fundação para a Ciência e Tecnologia.

Cell Reports, Arts et al.: "Immunometabolic pathways in BCG-induced trained immunity" http://www.cell.com/cell-reports/fulltext/S2211-1247(16)31552-2

Cell Reports (@CellReports), published by Cell Press, is a weekly open-access journal that publishes high-quality papers across the entire life sciences spectrum. The journal features reports, articles, and resources that provide new biological insights, are thought-provoking, and/or are examples of cutting-edge research. Visit: http://www.cell.com/cell-reports. To receive Cell Press media alerts, contact press@cell.com.

Cell Press

Related Tuberculosis Articles:

Old target, new mechanism for overcoming tuberculosis resistance
In strains of tuberculosis that have developed drug resistance mutations, researchers have identified a secondary pathway that can be activated to reinstate drug sensitivity.
Researchers use tiny 3-D spheres to combat tuberculosis
Researchers at the University of Southampton have developed a new 3-D system to study human infection in the laboratory.
How the tuberculosis vaccine may protect against other diseases
The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear.
Tuberculosis bacteria find their ecological niche
An international team of researchers have isolated and analyzed genetically tuberculosis bacteria from several thousand patients from over a hundred countries.
Tuberculosis and HIV co-infection
The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.
More Tuberculosis News and Tuberculosis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.